Diabetes has been recognized as an important risk factor for a variety of intracellular
bacterial infections, but research into the dysregulated immune mechanisms contributing to …

Since the successful conquest of many acute, communicable (infectious) diseases through
the use of vaccines and antibiotics, the currently most prevalent diseases are chronic and …

Objectives Anti-inflammatory therapeutic approaches are considered for the management of
type 2 diabetes and for the prevention of its complications. There is limited evidence …

Objective To evaluate and summarize the association between interleukin (IL)
concentrations and diabetes mellitus (DM) and its complications. Methods Meta-analyses …

The management of patients with diabetes mellitus (DM) in the era of the COVID-19
pandemic can be challenging. Even if they are not infected, they are at risk of dysregulated …

Diabetes mellitus (DM) is a metabolic inflammatory disease with a high incidence
worldwide. Patients with DM are at a high risk for all types of infections. Type 1 DM is …

Type 2 Diabetes Mellitus (T2DM) is a chronic inflammatory disorder that is characterized by
chronic hyperglycemia and impaired insulin signaling which in addition to be caused by …

Background:“Cytokine storm” has been used to implicate increased cytokine levels in the
pathogenesis of serious clinical conditions. Similarities with Severe Acute Respiratory …

Recently, substantial evidence has emerged that the liver contributes significantly to the
circulating levels of follistatin and that circulating follistatin is tightly regulated by the …

Systemic inflammation is often associated with impaired glucose metabolism. We therefore
studied the activation of inflammatory pathway intermediates that interfere with glucose …